OCULAR IMMUNOLOGY AND INFLAMMATION, vol.25, no.1, pp.62-70, 2017 (SCI-Expanded)
Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.